The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 517-520

  Barcz, Ewa ^a   Sommer, Ewa ^a   Sokolnicka, Irena ^a   Gawrychowski, Krzysztof ^b   Roszkowska Purska, Katarzyna ^b   Janik, Przemyslaw ^b   Skopinska Rózewska, Ewa ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Angiogenesis; Basic fibroblast growth factor; IL 8; Ovarian cancer; Theobromine; Vascular endothelial growth factor

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTERLEUKIN 8; THEOBROMINE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0031910614     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.517     Document Type: Article

References (24)

1. Rak JW, StCroix BD and Kerbel RS: Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs 6: 3-18, 1995.
2. Folkman J and Shing Y: Angiogenesis. J Biochem Chem 267: 10931-10934, 1992.
3. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
4. Folkman J, Watson K, Ingber D and Hanah D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.
5. Findlay JK: Angiogenesis in reproductive tissues. J Endocrinol 111: 357-366, 1986.
6. Modlich U, Kaup FJ and Augustin HG: Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74: 771-780, 1996.
7. van Diest PJ, Zevering JP, Zevering LC and Baak JPA: Prognostic value of microvessel quantitation in cisplatin treated FIGO 3 and 4 ovarian cancer patients. Path Res Pract 191: 25-30, 1995.
8. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML and Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147: 33-41, 1995.
9. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Damme JV and Kunkel SL: Role of CXC chemokines as regulators of angiogenesis in lung cancer. J Leukocyte Biol 57: 752-762, 1995.
10. Strieter RM, Polverini PJ, Arenberg DA and Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 4: 155-160, 1995.
11. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989.
12. Kamat BR, Brown LF, Manseau EJ, Senger DR and Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146: 157-165, 1995
13. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Siossat TM and Dvorak HF: Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res 55: 360-368, 1995.
14. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM and Dvorak HF: Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 55: 376-385, 1995.
15. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Advan Cancer Res 59: 115-158, 1992.
16. DiBlasio AM, Cremonesi L. Vigano P, Ferrari M, Gospodarowicz D, Vignali M and Jaffe RB: Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am J Obstet Gynecol 169: 1517-1523, 1993.
17. Crickard K, Gross JL, Yoonessi M, Lele S, Herblin WF and Eidsvoog K: Basic fibroblast growth factor and receptor expression in human ovarian cancer. Gynecol Oncol 55: 277-284, 1994.
18. Dusseau JW, Hutchins PM, Danielle S and Malbasa: Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circulation Res 59: 163-170, 1986.
19. Mukhopadhyay D, Tsiokas L, Zhou X, Foster D, Brugge JS and Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Scr activation. Nature 375: 577-581, 1995.
20. Meininger CJ, Schelling ME and Granger HJ: Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255: H554-H562, 1988.
21. Meininger CJ and Granger HJ: Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 258: H198-H206, 1990.
22. Teuscher E and Weidlich V: Adenosine nucleotides, adenosine, and adenine as angiogenesis factors. Biomed Biochim Acta 3: 493-495, 1985.
23. Sidky YA and Auerbach R: Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of the graft-versus host reaction. J Exp Med 141: 1084-1100, 1975.
24. Skopinska-Rózewska E, Sommer E, Demkow U, Chorostowska-Wynimko J, Balan B, Rózycka B, Barcz E, Filewska M, Mlekodaj S, Rudzinski P, Seweryniak W, Caban P, Kupis W, Bogdan J, Usiekniewicz P, Gatarek J and Langfort R: Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer. Annales Academiae Medicae Bialostocensis 42: 287-294, 1997.